Search results

630 results

Sorted by Relevance . Sort by Date

  1. Acne Vulgaris: Management

    In development [GID-NG10109] Expected publication date: 25 June 2021

  2. Shared decision making

    In development [GID-NG10120] Expected publication date: 17 June 2021

  3. Diabetes update

    In development [GID-NG10152] Expected publication date: TBC

  4. Weight Management

    In development [GID-NG10182] Expected publication date: 22 June 2023

  5. Pernicious anaemia

    In development [GID-NG10176] Expected publication date: 01 November 2023

  6. Inducing labour (update)

    In development [GID-NG10082] Expected publication date: 14 October 2021

  7. Antenatal care

    In development [GID-NG10096] Expected publication date: 19 August 2021

  8. Bronchiolitis in Children

    In development [GID-NG10222] Expected publication date: 13 August 2021

  9. Procalcitonin testing for diagnosing and monitoring sepsis (ADVIA Centaur BRAHMS PCT assay, BRAHMS PCT Sensitive Kryptor assay, Elecsys BRAHMS PCT assay, LIAISON BRAHMS PCT assay and VIDAS BRAHMS PCT assay) (DG18)

    NICE has assessed the procalcitonin tests (ADVIA Centaur BRAHMS PCT assay, BRAHMS PCT Sensitive Kryptor assay, Elecsys BRAHMS PCT assay, LIAISON BRAHMS PCT

  10. Integrated sensor-augmented pump therapy systems for managing blood glucose levels in type 1 diabetes (the MiniMed Paradigm Veo system and the Vibe and G4 PLATINUM CGM system) (DG21)

    Evidence-based recommendations on the MiniMed Paradigm Veo and Vibe and G4 PLATINUM CGM sensor-augmented pump therapy systems, which combine continuous glucose

  11. PlGF-based testing to help diagnose suspected pre-eclampsia (Triage PlGF test, Elecsys immunoassay sFlt-1/PlGF ratio, DELFIA Xpress PlGF 1-2-3 test, and BRAHMS sFlt-1 Kryptor/BRAHMS PlGF plus Kryptor PE ratio) (DG23)

    Evidence-based recommendations on PlGF-based testing to help diagnose suspected pre-eclampsia (Triage PlGF test, Elecsys immunoassay sFlt-1/PlGF ratio, DELFIA